Literature DB >> 35969309

Magnetic guanidyl-functionalized covalent organic framework composite: a platform for specific capture and isolation of phosphopeptides and exosomes.

Bing Wang1, Baichun Wang1, Quanshou Feng1, Xiang Fang2, Xinhua Dai3, Yinghua Yan4, Chuan-Fan Ding1.   

Abstract

A guanidine-functionalized (GF) covalent organic framework (COF) nanocomposite has been developed by a post-synthetic approach for specific capture and separation of phosphopeptides and exosomes. The abundant binding sites on COF can immobilize a large number of gold nanoparticles (AuNPs), which can be used to react with amino groups to graft polyethyleneimine (PEI). Finally, Fe3O4@COF@Au@PEI-GF is obtained through the reaction of PEI and guanidyl group for phosphopeptides and exosomes detection. This composite shows a low detection limit (0.02 fmol), size exclusion effect (β-casein digests:Albumin from bovine serum protein = 1:10,000), good reusability (10 cycles), and high selectivity (β-casein digests:Albumin from bovine serum digests = 1:10,000). For complex biological sample, 4 phosphopeptides can be successfully identified from human serum. Furthermore, for the first time, we used guanidyl-functionalized probe to capture exosomes in human serum, providing a new method for enriching exosomes. The above experiments showed that Fe3O4@COF@Au@PEI-GF not only effectively enrich phosphopeptides and remove macromolecular proteins, but also successfully separate and capture exosomes. This demonstrates the great potential of this composite for the specific enrichment of phosphopeptides and isolation of exosomes.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Keywords:  Covalent organic framework; Enrichment; Exosomes; Mass spectrometry; Phosphopeptides; SDS-Page; Size exclusion

Mesh:

Substances:

Year:  2022        PMID: 35969309     DOI: 10.1007/s00604-022-05394-3

Source DB:  PubMed          Journal:  Mikrochim Acta        ISSN: 0026-3672            Impact factor:   6.408


  23 in total

1.  Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes.

Authors:  Bow J Tauro; David W Greening; Rommel A Mathias; Hong Ji; Suresh Mathivanan; Andrew M Scott; Richard J Simpson
Journal:  Methods       Date:  2012-01-21       Impact factor: 3.608

2.  Cancer exosomes trigger fibroblast to myofibroblast differentiation.

Authors:  Jason Webber; Robert Steadman; Malcolm D Mason; Zsuzsanna Tabi; Aled Clayton
Journal:  Cancer Res       Date:  2010-11-23       Impact factor: 12.701

3.  A cell ELISA based method for exosome detection in diagnostic and therapeutic applications.

Authors:  Shabanali Khodashenas; Saeed Khalili; Mehdi Forouzandeh Moghadam
Journal:  Biotechnol Lett       Date:  2019-04-08       Impact factor: 2.461

Review 4.  Separation of distinct exosome subpopulations: isolation and characterization approaches and their associated challenges.

Authors:  Karishma Singh; Ruchika Nalabotala; Kevin M Koo; Sudeep Bose; Ranu Nayak; Muhammad J A Shiddiky
Journal:  Analyst       Date:  2021-06-14       Impact factor: 4.616

5.  Proteomics comparison of exosomes from serum and plasma between ultracentrifugation and polymer-based precipitation kit methods.

Authors:  Feng Cao; Ying Gao; Qiao Chu; Qi Wu; Lin Zhao; Tao Lan; Liang Zhao
Journal:  Electrophoresis       Date:  2019-11-13       Impact factor: 3.535

6.  Hydrophilic tripeptide combined with magnetic titania as a multipurpose platform for universal enrichment of phospho- and glycopeptides.

Authors:  Nianrong Sun; Zidan Wang; Jiawen Wang; Hemei Chen; Hao Wu; Shun Shen; Chunhui Deng
Journal:  J Chromatogr A       Date:  2019-02-18       Impact factor: 4.759

7.  Glutathione-functionalized magnetic thioether-COFs for the simultaneous capture of urinary exosomes and enrichment of exosomal glycosylated and phosphorylated peptides.

Authors:  Fangfang Xiong; Jiaxin Jia; Jiutong Ma; Qiong Jia
Journal:  Nanoscale       Date:  2022-01-20       Impact factor: 7.790

8.  High-purity capture and release of circulating exosomes using an exosome-specific dual-patterned immunofiltration (ExoDIF) device.

Authors:  Yoon-Tae Kang; Young Jun Kim; Jiyoon Bu; Young-Ho Cho; Sae-Won Han; Byung-In Moon
Journal:  Nanoscale       Date:  2017-09-21       Impact factor: 7.790

9.  Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.

Authors:  Sonia A Melo; Linda B Luecke; Christoph Kahlert; Agustin F Fernandez; Seth T Gammon; Judith Kaye; Valerie S LeBleu; Elizabeth A Mittendorf; Juergen Weitz; Nuh Rahbari; Christoph Reissfelder; Christian Pilarsky; Mario F Fraga; David Piwnica-Worms; Raghu Kalluri
Journal:  Nature       Date:  2015-06-24       Impact factor: 69.504

10.  A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro.

Authors:  Hongxiang Wei; Jinyuan Chen; Shenglin Wang; Feihuan Fu; Xia Zhu; Chaoyang Wu; Zhoujie Liu; Guangxian Zhong; Jianhua Lin
Journal:  Int J Nanomedicine       Date:  2019-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.